{"id":"https://openalex.org/W1998950163","doi":"https://doi.org/10.1001/archdermatol.2011.354","title":"Prevention of Glucocorticoid-Induced Osteoporosis in Immunobullous Diseases With Alendronate: A Randomized, Double-blind, Placebo-Controlled Study","display_name":"Prevention of Glucocorticoid-Induced Osteoporosis in Immunobullous Diseases With Alendronate: A Randomized, Double-blind, Placebo-Controlled Study","publication_year":2011,"publication_date":"2011-11-22","ids":{"openalex":"https://openalex.org/W1998950163","doi":"https://doi.org/10.1001/archdermatol.2011.354","mag":"1998950163","pmid":"https://pubmed.ncbi.nlm.nih.gov/22105813"},"language":"en","primary_location":{"id":"doi:10.1001/archdermatol.2011.354","doi":"https://doi.org/10.1001/archdermatol.2011.354","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archdermatol.2011.354","pdf_url":null,"source":{"id":"https://openalex.org/S115046667","display_name":"Archives of Dermatology","issn_l":"0003-987X","issn":["0003-987X","1538-3652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089469707","display_name":"Shang\u2010Ian Tee","orcid":"https://orcid.org/0000-0002-8710-3453","observed_orcids":["https://orcid.org/0000-0002-8710-3453"]},"institutions":[{"id":"https://openalex.org/I1287551835","display_name":"National Skin Centre","ror":"https://ror.org/000p7hm12","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I1287551835"]}],"countries":["SG"],"is_corresponding":true,"raw_author_name":"Shang-Ian Tee","raw_affiliation_strings":["National Skin Centre, Singapore. sitee@nsc.gov.sg","National Skin Centre, Singapore\u2028"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Skin Centre, Singapore. sitee@nsc.gov.sg","institution_ids":["https://openalex.org/I1287551835"]},{"raw_affiliation_string":"National Skin Centre, Singapore\u2028","institution_ids":["https://openalex.org/I1287551835"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089469707"],"corresponding_institution_ids":["https://openalex.org/I1287551835"],"apc_list":null,"apc_paid":null,"fwci":1.0559,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.77628516,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"148","issue":"3","first_page":"307","last_page":"307"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucocorticoid-induced-osteoporosis","display_name":"glucocorticoid-induced osteoporosis","score":0.949999988079071},{"id":"https://openalex.org/keywords/alendronate","display_name":"alendronate","score":0.9520000219345093},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9409999847412109},{"id":"https://openalex.org/keywords/bone-mineral-density","display_name":"bone mineral density","score":0.9409999847412109},{"id":"https://openalex.org/keywords/calcium-and-vitamin-d-supplementation","display_name":"calcium and vitamin D supplementation","score":0.7940000295639038},{"id":"https://openalex.org/keywords/systemic-corticosteroid-therapy","display_name":"systemic corticosteroid therapy","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9517842531204224},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8038371801376343},{"id":"https://openalex.org/C2775854910","wikidata":"https://www.wikidata.org/wiki/Q4844892","display_name":"Femoral neck","level":3,"score":0.7592712640762329},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.6950100660324097},{"id":"https://openalex.org/C2779809032","wikidata":"https://www.wikidata.org/wiki/Q420057","display_name":"Alendronic acid","level":4,"score":0.6368016004562378},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.5281657576560974},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5012590885162354},{"id":"https://openalex.org/C2779329777","wikidata":"https://www.wikidata.org/wiki/Q2304401","display_name":"Bone density","level":3,"score":0.4732057452201843},{"id":"https://openalex.org/C2777083390","wikidata":"https://www.wikidata.org/wiki/Q1367706","display_name":"Osteopenia","level":4,"score":0.45299196243286133},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4408724009990692},{"id":"https://openalex.org/C2776886416","wikidata":"https://www.wikidata.org/wiki/Q4941567","display_name":"Bone mineral","level":3,"score":0.43510907888412476},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41374385356903076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38931411504745483},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37069469690322876},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3538966774940491},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06336429715156555},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010390","descriptor_name":"Pemphigoid, Benign Mucous Membrane","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010390","descriptor_name":"Pemphigoid, Benign Mucous Membrane","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010391","descriptor_name":"Pemphigoid, Bullous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010391","descriptor_name":"Pemphigoid, Bullous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010392","descriptor_name":"Pemphigus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010392","descriptor_name":"Pemphigus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012846","descriptor_name":"Singapore","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012872","descriptor_name":"Skin Diseases, Vesiculobullous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012872","descriptor_name":"Skin Diseases, Vesiculobullous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014807","descriptor_name":"Vitamin D","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015519","descriptor_name":"Bone Density","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016107","descriptor_name":"Epidermolysis Bullosa Acquisita","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016107","descriptor_name":"Epidermolysis Bullosa Acquisita","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019386","descriptor_name":"Alendronate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019386","descriptor_name":"Alendronate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/archdermatol.2011.354","doi":"https://doi.org/10.1001/archdermatol.2011.354","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archdermatol.2011.354","pdf_url":null,"source":{"id":"https://openalex.org/S115046667","display_name":"Archives of Dermatology","issn_l":"0003-987X","issn":["0003-987X","1538-3652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatology","raw_type":"journal-article"},{"id":"pmid:22105813","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22105813","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of dermatology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334737","display_name":"National Medical Research Council","ror":"https://ror.org/04x3cxs03"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W185353390","https://openalex.org/W1490805577","https://openalex.org/W1528597514","https://openalex.org/W1573883118","https://openalex.org/W1581311200","https://openalex.org/W1585040018","https://openalex.org/W1684483569","https://openalex.org/W1948439712","https://openalex.org/W1968384266","https://openalex.org/W1971610058","https://openalex.org/W1976278202","https://openalex.org/W1983391342","https://openalex.org/W1985500418","https://openalex.org/W1990551708","https://openalex.org/W2019633751","https://openalex.org/W2022471807","https://openalex.org/W2035409850","https://openalex.org/W2037206886","https://openalex.org/W2040597184","https://openalex.org/W2045947279","https://openalex.org/W2049219019","https://openalex.org/W2050267197","https://openalex.org/W2055035482","https://openalex.org/W2095741166","https://openalex.org/W2105648357","https://openalex.org/W2107222134","https://openalex.org/W2107789045","https://openalex.org/W2111992737","https://openalex.org/W2117797268","https://openalex.org/W2123609687","https://openalex.org/W2124011858","https://openalex.org/W2134460604","https://openalex.org/W2135327653","https://openalex.org/W2143018650","https://openalex.org/W2144722417","https://openalex.org/W2148270586","https://openalex.org/W2149141806","https://openalex.org/W2164229113","https://openalex.org/W2171133944","https://openalex.org/W2171709369","https://openalex.org/W2313685231","https://openalex.org/W2314674563","https://openalex.org/W2323358347","https://openalex.org/W2335475908","https://openalex.org/W2342762318","https://openalex.org/W3172713090","https://openalex.org/W4237907339","https://openalex.org/W4250477855","https://openalex.org/W4407799256"],"related_works":["https://openalex.org/W2115647238","https://openalex.org/W2162782837","https://openalex.org/W2093196075","https://openalex.org/W2314674563","https://openalex.org/W1964296084","https://openalex.org/W2053409801","https://openalex.org/W2413334457","https://openalex.org/W337812723","https://openalex.org/W2077804411","https://openalex.org/W1970056216"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,109,113,141,149,153,159,168,172,182,187,195,202,229,235,244,269,276,306],"efficacy":[4],"and":[5,54,112,146,152,165,171,201,243,275],"safety":[6],"of":[7,62,122,246],"oral":[8,74,300],"alendronate":[9,75,142,183,230,283],"sodium":[10,76],"therapy":[11,291],"once":[12],"daily":[13],"in":[14,19,43,103,138,140,158,178,181,215,228,234,265,292],"preventing":[15],"glucocorticoid-induced":[16],"bone":[17,104],"loss":[18],"patients":[20,68,87,124,293],"with":[21,26,92,186,282,294,309],"immunobullous":[22,52,295],"skin":[23],"diseases":[24],"treated":[25],"long-term":[27],"glucocorticoid":[28,64],"therapy.":[29,65,284],"DESIGN:":[30],"A":[31,38,120],"12-month":[32],"randomized,":[33],"double-blind,":[34],"placebo-controlled":[35],"trial.":[36],"SETTING:":[37],"tertiary":[39],"referral":[40],"dermatology":[41],"center":[42],"Singapore.":[44],"PARTICIPANTS:":[45],"Patients":[46],"newly":[47],"diagnosed":[48],"as":[49],"having":[50],"an":[51],"disease":[53],"deemed":[55],"to":[56,71,288],"require":[57],"at":[58,108,116,148,167,193,267],"least":[59],"6":[60],"months":[61,223],"systemic":[63],"INTERVENTIONS:":[66],"The":[67,135,176],"were":[69,133,240,261],"randomized":[70],"receive":[72],"either":[73],"(10":[77],"mg/d)":[78],"or":[79],"a":[80,211],"matching":[81],"placebo":[82,129,160,188,236],"for":[83],"12":[84,117,222],"months.":[85,118],"All":[86],"also":[88,210],"received":[89],"concurrent":[90],"calcium":[91],"vitamin":[93],"D,":[94],"2":[95],"tablets":[96],"daily.":[97],"MAIN":[98],"OUTCOME":[99],"MEASURES:":[100],"Percent":[101],"change":[102,137],"mineral":[105],"density":[106],"(BMD)":[107],"lumbar":[110,150,169,196,270],"spine":[111,151,170,197,271],"femoral":[114,154,173,203,277],"neck":[115,204,278],"RESULTS:":[119],"total":[121],"29":[123],"(alendronate":[125],"[n":[126,130],"=":[127,131,199,206,257,273,280],"15],":[128],"14])":[132],"evaluated.":[134],"percent":[136],"BMD":[139,179,266],"group":[143,184,189,231],"was":[144,163,190,209],"+3.7%":[145],"+3.5%":[147],"neck,":[155,174],"respectively,":[156],"whereas":[157],"group,":[161],"it":[162,303],"-1.4%":[164],"-0.7%":[166],"respectively.":[175],"increase":[177],"observed":[180],"compared":[185],"statistically":[191,212,262],"significant":[192,213,263],"both":[194,253,268],"(P":[198,205,256,272,279],".01)":[200,227,274,281],".01).":[207],"There":[208,260],"decrease":[214],"serum":[216],"heat-labile":[217],"alkaline":[218],"phosphatase":[219],"levels":[220],"after":[221],"(-32.6%,":[224],"P":[225],"<":[226],"but":[232],"not":[233,249],"group.":[237],"Adverse":[238],"events":[239],"generally":[241],"minor,":[242],"frequency":[245],"occurrence":[247],"did":[248],"differ":[250],"significantly":[251],"between":[252],"treatment":[254],"groups":[255],".59).":[258],"CONCLUSIONS:":[259],"increases":[264],"It":[285],"is":[286],"imperative":[287],"use":[289],"bisphophonate":[290],"disorders":[296],"who":[297],"are":[298],"receiving":[299],"corticosteroids":[301],"because":[302],"largely":[304],"prevents":[305],"morbidity":[307],"associated":[308],"low":[310],"BMD.":[311]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}